- Home
- Drug Delivery Technology Industry
- Transmucosal Delivery Market and Forecasts, May 2013
Industries
Top countries
Publication dates
All regions
data types
- All
- Company Data (34)
- Industry Data
Transmucosal Delivery Market and Forecasts, May 2013
You might be interested in: drug delivery, anesthetics, buprenorphine, more »
industry reports
company reports
Drug Delivery in The United States : Innovation and Technology Trends
- Industry report
- August 2011
- 6 pages
... Patches contain a larger amount of the drug substance than what is intended to be delivered to the patient. This excess amount of drug substance is needed to facilitate delivery of the intended amount ...
- Industries: Drug Delivery Technology
- Countries: United States
Drug Delivery Technology Industry Brief
- Industry report
- September 2012
- 24 pages
... Between the devices for aerosol delivery performance. Therefore it is imperative that the generic (test) article matches the delivery system of the refer- ence article as closely as possible. For p ...
- Industries: Drug Delivery Technology
Buprenorphine Market in The United States
- Industry report
- January 2012
- 37 pages
... Nov-11 butrans Cumulative prescription sales since launch ($million )1 Uptake suggests strong interest in buprenorphine for pain transmucosal preference (2:1) provides significant ...
- Industries: Drug and Medication
- Countries: United States
U.S. Buprenorphine Industry
- Industry report
- May 2012
- 32 pages
... Drug delivery technologies to develop and commercialize new applications of proven therapeutics Use fda 505(b)(2) regulatory process Ability to bring products to market faster, with less risk ...
- Industries: Drug and Medication
- Countries: United States
Drug and Medication in The United States : Innovation and Technology Trends
- Industry report
- June 2012
- 25 pages
- by Corporation
... Sufentanil nanotab transmucosal pk avoiding the peaks and troughs of iv pca delivery accelerate. Innovate. Alleviate. 9 Lipophilic drugs transit from plasma to effector site in the brain more rapidly than ...
- Industries: Drug and Medication
- Countries: United States
Medication Sector in The United States
- Industry report
- April 2012
- 8 pages
... Require additional tools to ensure safety. Additionally, the fdaaa states that the program shall not be Unduly burdensome on patient access And shall Minimize the burden on the health care delivery ...
- Industries: Drug and Medication
- Countries: United States
Managed Care Market Analysis in The United States
- Industry report
- February 2013
- 72 pages
... Attorney generals and local law enforcement Dea will continue to host until disposal regulations are final Constructive transfer issues delivery of a patient-specific controlled substance ...
- Industries: Managed Care
- Countries: United States
Protein Market in Canada
- Industry report
- March 2012
- 5 pages
... Environment in order to present the antigen in a highly efficient manner, but can also act as an efficient transmucosal carrier molecule and delivery system for plant-derived subunit vaccines [8 ...
- Industries: Biopharmaceutical
- Countries: Canada
U.S. Drug and Medication Business Analysis
- Industry report
- May 2012
- 77 pages
... Class development capabilities page 10 orexo business model with significant advantages New products improved product treatment to new areas our methodology ip protected drug delivery ...
- Industries: Drug and Medication
- Countries: United States
Vaccine Sector (vaccine, monoclonal antibody) in Canada
- Industry report
- December 2011
- 7 pages
... Issn:2155-9899 jcci, an open access journal vaccine development and immune response highly efficient manner, but can also act as an efficient transmucosal carrier molecule and delivery system for plant ...
- Industries: Biopharmaceutical
- Countries: Canada
» Purchase Premium Reports (From $ 125 - $ 10 000)
28 reports for Transmucosal Delivery
United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery
- $ 10 000
- Industry report
- November 2012
- by Frost & Sullivan
Research Objectives ?Understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients in key treatment settings such as home, office, or infusion center. ?Identify physician ...
Reportlinker.com © Copyright 2013. All rights reserved.
